Largest study yet shows 'compelling' benefit of HPV vaccination
There are dramatic decreases in HPV infection, genital warts and precancerous cervical lesions
1st July 2019
Drawing on a decade of global data, researchers have sketched a bright picture on the impact of HPV vaccination, including cross-protection, herd immunity and ultimately widespread disease reduction.
Data from more than 60 million patients has been “compelling”, write the authors, saying the impact of HPV vaccination programs in 14 high-income countries worldwide has been substantial.
“Our results provide strong evidence of HPV vaccination working to prevent cervical cancer in real-world settings, as both the cause and proximal disease endpoints are